PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 30 PubMed articles · model: gemma4:31b
Summary
Background
Traditional uses
Active compounds
Mechanism of action
Clinical evidence
Showed promising effects on anxiety in animal models [PMID:33480339]
Mimosa pudica-mediated strontium nanoparticles demonstrated anti-inflammatory activity in bovine and egg albumin denaturation and membrane stabilization assays [PMID:38882793]
Safety & adverse effects
Evidence summary
PubMed sources
- 1.PMID: 33480339 (2022) — Anti-anxiety Properties of Selected Medicinal Plants. · Current pharmaceutical biotechnology
- 2.PMID: 32375332 (2020) — Mechanical Signaling in the Sensitive Plant Mimosa pudica L. · Plants (Basel, Switzerland)
- 3.PMID: 37520120 (2023) — Mimosa pudica mucilage nanoparticles of losartan potassium: Characterization and pharmacodynamics evaluation. · Saudi pharmaceutical journal : SPJ : the official publication of the Saudi Pharmaceutical Society
- 4.PMID: 38882793 (2024) — Green Synthesis of Mimosa pudica-Mediated Strontium Nanoparticles and its Anti-Inflammatory Activity. · Journal of pharmacy & bioallied sciences
- 5.PMID: 23055637 (2012)